CELLAVISION AB (publ) Interim report for the period January 1 - September 30, 2008

Fifth consecutive quarter of profitability

*    Net sales for the period of January to September rose by 13
  percent to SEK 62.1 million (55.1),
  of which the third quarter accounted for SEK 20.8 million (21.1).
*    The operating profit for the period was SEK 6.3 million (0.1)
  and for the third quarter
  SEK 3.6 million (3.8).
*    Earnings per share for the period amounted to SEK 0.25 (-0.01).
  For the third quarter the earnings per share were SEK 0.14 (0.16).
*    Cash and cash equivalents amounted to SEK 11.3 million (16.2) at
  the end of the interim period.

Important events during the quarter
*    The exclusive distribution agreement with Sysmex Europe was
  extended until 2010.
*    Official approval to market the analyzer CellaVision® DM in
  Japan was received.
*    A reference laboratory chain in Canada purchased CellaVision
  DM96 instruments for two laboratories.
*   The application for body fluids was approved for sale in Canada -
  the first orders were received.



  CellaVision in summary
                                     Jan 1-      Jan 1-    Full year
  (MSEK)           Q3 2008 Q3 2007   Sep 30,    Sep 30,      2007
                                      2008        2007
  Net sales           20.8    21.1        62.1       55.1        74.6
  Gross profit        16.6    11.4        42.4       31.2        45.3
  Operating result     3.6     3.8         6.3        0.1         3.1
  Net result           3.4     3.7         6.0       -0.2         2.6
  Cash flow           -5.6     7.5        -5.0       -0.5        -0.4



CEO's comment"It is exciting to report a positive result for the fifth quarter  in
a row - a reflection of our steady sales growth. The establishment of
our own  sales organisation  in the  US is  progressing according  to
plan, and I am hoping to see some results from our investment  before
the end of the  year. At the same  time our partnership with  Sysmex,
our distributor in the US, is continuously successful.

The individual  quarters  are difficult  to  compare because  we  are
dependent on the  distributor's sales success  and inventory  levels.
The revenue from the various geographical markets varies between  the
periods, which is entirely normal in this industry. Coupled with  the
dollar exchange rate,  the positive  result of the  third quarter  is
mainly due to sales in North America. We are however expecting a more
even distribution  between  Europe and  North  America for  the  full
year."


For further information, please contact:
Yvonne Mårtensson, CEO. Phone: 0708 33 77 82, e-mail:
yvonne.martensson@cellavision.se
Johan Wennerholm, CFO. Phone: 0708 33 81 68, e-mail:
johan.wennerholm@cellavision.se


Download the report by pressing the link below.